FDA Speeds Up Development of SOTIO’s Targeted Sarcoma Drug SOT106
This article reports that the U.S. Food and Drug Administration (FDA) has granted two special designations to SOT106, an experimental
Read More
Author: mattstrongalldaylong
Circulating Tumor DNA Profiling Defines Risk In Patients With Ewing Sarcoma
This study focuses on improving how doctors evaluate risk for patients diagnosed with Ewing Sarcoma. Traditionally, doctors relied mostly on
Read More
A Rebirth Begins
It’s been a rough past few weeks for Matt, but today he reached an important milestone. He is officially in
Read More
No Place Like Home
We went in to the infusion center on Friday for a regularly scheduled visit. We knew it would be a
Read More
Transition Bio and Little Warrior Foundation Partner to Advance Breakthrough Ewing Sarcoma Treatments
Transition Bio, a biopharmaceutical company specializing in drug discovery, has partnered with the Little Warrior Foundation, a non-profit dedicated to
Read More2026 RTCS Fundraiser And Race Day Photo Viewer
A collection of fundraising activities and race day photos submitted by Team Matt Strong members from the 2026 Race To
Read More2026 RTCS Fundraiser And Race Day Photo Upload
This page was built so Team Matt Strong members can share some of the great fundraising activities going on behind
Read More
Menin Inhibition Impairs Metastatic Ewing Sarcoma
Ewing sarcoma is an aggressive bone and soft tissue cancer that frequently recurs at distant body sites, leading to poor
Read More
2026 Race To Cure Sarcoma – Tampa
Upload Your Fundraising And Race Day Photos Here View RTCS 2026 Photos Here Time seems to be flying by a
Read More
Birthday Week – Round 6 Begins
Today Matt began his last round (Round 6) of chemotherapy treatment. It’s somewhat biiter-sweet as he will be spending his
Read More